Measuring Apo-B levels, in addition to traditional lipid parameters, may provide valuable insights into an individual’s risk of developing T2DM and could help guide targeted interventions aimed at improving both cardiovascular and metabolic outcomes. The gene discussed is APOB; the disease is type 2 diabetes mellitus.